OptimizeRx Corp - Common Stock (OPRX)

Q3 2020 13F Holders as of 9/30/2020

Type / Class
Equity / Common Stock
Shares outstanding
18.5M
Number of holders
65
Total 13F shares, excl. options
8.85M
Shares change
+776K
Total reported value, excl. options
$184M
Value change
+$17.6M
Put/Call ratio
0
Number of buys
31
Number of sells
-31
Price
$20.85

Significant Holders of OptimizeRx Corp - Common Stock (OPRX) as of Q3 2020

73 filings reported holding OPRX - OptimizeRx Corp - Common Stock as of Q3 2020.
OptimizeRx Corp - Common Stock (OPRX) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 8.85M shares of 18.5M outstanding shares and own 47.79% of the company stock.
Largest 10 shareholders include BlackRock Inc. (937K shares), AWM Investment Company, Inc. (908K shares), G2 Investment Partners Management LLC (889K shares), BLAIR WILLIAM & CO/IL (765K shares), AVENIR CORP (729K shares), First Light Asset Management, LLC (590K shares), WASATCH ADVISORS INC (450K shares), Handelsbanken Fonder AB (390K shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (319K shares), and Venator Capital Management Ltd. (313K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.